Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer
跨物种基因组和功能分析确定使用 CHK1 抑制剂和核苷酸还原酶抑制剂的联合疗法治疗三阴性乳腺癌
期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/bcr3230
Christina N Bennett, Christine C Tomlinson, Aleksandra M Michalowski, Isabel M Chu, Dror Luger, Lara R Mittereder, Olga Aprelikova, James Shou, Helen Piwinica-Worms, Natasha J Caplen, Melinda G Hollingshead, Jeffrey E Green
